G. Böhme

发表

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

M. Parmentier, A. Imperato, B. Roques, 1999, Science.

A Role for Nitric Oxide in Long‐term Potentiation

G. Böhme, J. Stutzmann, C. Bon, 1992, The European journal of neuroscience.

Electrophysiological studies with new CCK analogs: Correlation with binding affinity on B-type receptors

B. Roques, G. Böhme, J. Stutzmann, 1989, Peptides.

RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis.

S. Mignani, G. Jahn, G. Böhme, 2001, The Journal of pharmacology and experimental therapeutics.

Pharmacological properties of ureido-acetamides, new potent and selective non-peptide CCKB/gastrin receptor antagonists.

B. Ducos, G. Böhme, M. Capet, 1994, European journal of pharmacology.

The effect of riluzole and mannitol on cerebral oedema after cryogenic injury in the mouse

A. Imperato, G. Böhme, J. Stutzmann, 1999, Neuroscience Letters.

Synthesis and pharmacological properties of 5H,10H‐imidazo[1,2‐a]indeno[1,2‐e]pyrazine‐4‐one, a new competitive AMPA/KA receptor antagonist

A. Imperato, S. Mignani, G. Böhme, 1999 .

Effects of selective μ- and δ-opioid peptides on kindled amygdaloid seizures in rats

B. Roques, G. Böhme, J. Stutzmann, 1987, Neuroscience Letters.

Riluzole prevents hyperexcitability produced by the mast cell degranulating peptide and dendrotoxin I in the rat.

C. Gottesmann, G. Böhme, J. Stutzmann, 1991, European journal of pharmacology.

Proconflict and electrocorticographic effects of drugs modulating GABAergic neurotransmission

G. Böhme, J. Stutzmann, J. Blanchard, 2004, Psychopharmacology.

Possible involvement of nitric oxide in long-term potentiation.

G. Böhme, J. Stutzmann, C. Bon, 1991, European journal of pharmacology.

A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease.

Y. Agid, R. Marconi, B. Oostra, 1999, Human molecular genetics.

CCK-A and CCK-B selective receptor agonists and antagonists modulate olfactory recognition in male rats

B. Roques, G. Böhme, J. Blanchard, 1994, Psychopharmacology.

CCK-A and CCK-B receptors enhance olfactory recognition via distinct neuronal pathways.

B. Roques, G. Böhme, P. Barnéoud, 1994, Learning & memory.

CholecystokininA and cholecystokininB receptors in neurons of the brainstem solitary complex of the rat: pharmacological identification.

P. Branchereau, J. Champagnat, M. Denavit-Saubié, 1992, The Journal of pharmacology and experimental therapeutics.

‘Anxiolytic’ effect of CCK-antagonists on plus-maze behavior in mice

G. Böhme, J. Stutzmann, J. Blanchard, 1991, Brain Research.

Excitatory effects of cholecystokinin in rat hippocampus: pharmacological response compatible with ‘central’- or B-type CCK receptors

G. Böhme, J. Stutzmann, J. Blanchard, 1988, Brain Research.

Differential electrographic patterns for specific μ- and δ-opioid peptides in rats

B. Roques, G. Böhme, J. Stutzmann, 1986 .

Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor-treated rats.

G. Böhme, J. Stutzmann, C. Bon, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Selective inhibition of inducible nitric oxide synthase prevents ischaemic brain injury

G. Böhme, J. Stutzmann, M. Plotkine, 1999, British journal of pharmacology.

An in vitro and in vivo study of early deficits in associative learning in transgenic mice that over‐express a mutant form of human APP associated with Alzheimer's disease

J. Delgado-García, R. Sánchez-Campusano, V. Blanchard, 2004, The European journal of neuroscience.

Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse

M. Parmentier, A. Imperato, C. Ledent, 2001, Behavioural Brain Research.

Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB(1) receptor knockout mice.

M. Parmentier, A. Imperato, C. Ledent, 1999, European journal of pharmacology.

Enhancement of memory in cannabinoid CB1 receptor knock-out mice.

M. Parmentier, A. Imperato, C. Ledent, 1999, European journal of pharmacology.

Impaired long-term potentiation induction in dentate gyrus of calretinin-deficient mice.

S. Schiffmann, H. Gurden, H. Lipp, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Calretinin expression as a critical component in the control of dentate gyrus long‐term potentiation induction in mice

S. Schiffmann, H. Gurden, M. Parmentier, 1998, The European journal of neuroscience.

[Cholecystokinins and their receptors. Functional aspects].

G. Böhme, J. Blanchard, 1992, Therapie.

Evidence for an endogenous cholecystokininergic balance in social memory.

B. Roques, G. Böhme, J. Blanchard, 1992, Neuroreport.

Investigation of behavioral and electrophysiological responses induced by selective stimulation of CCKB receptors by using a new highly potent CCK analog, BC 264

J. Féger, J. Crawley, B. Roques, 1990, Synapse.

8-Methylureido-4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno[1,2-e]pyrazines: highly potent in vivo AMPA antagonists.

A. Imperato, S. Mignani, G. Böhme, 2000, Bioorganic & medicinal chemistry letters.

Evaluation of Putative Anxiolytics in the Elevated Plus-Maze Test

G. Böhme, M. Reibaud, 1993 .

The Ureidoacetamides, a Novel Family of Non‐peptide CCK‐B/Gastrin Antagonists

G. Böhme, J. Stutzmann, M. Capet, 1994, Annals of the New York Academy of Sciences.